Leonteq Securities’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Leonteq Securities's BBIO Position: Q3 2026 in Review
Leonteq Securities increased its BridgeBio Pharma (BBIO) stake by 37% in Q3 2026, buying an estimated $117K and bringing the position to 5,513 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #389.
Leonteq Securities first reported a position in BBIO in Q1 2024 and has held it in 11 quarters since. 465 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Leonteq Securities held 5,513 shares of BridgeBio Pharma worth $363K as of Q3 2026.
- Leonteq Securities bought 1,500 BridgeBio Pharma shares in Q3 2026, an estimated $117K.
- BridgeBio Pharma made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #389 holding.
- Leonteq Securities first reported a position in BridgeBio Pharma in Q1 2024 and has held it in 11 quarters since.
- 465 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.